For example, doxorubicin, used to treat breast cancer, bladder cancer, lymphoma, and acute lymphoblastic leukemia (ALL), is less effective in cells expressing p-glycoprotein (p-gp), as p-gp pumps the drug out, protecting cells from ER stress [108]. This evidence concerns the gene PGP and breast carcinoma.